Expression of CXCR4 is associated with axillary lymph node status in patients with early breast cancer

被引:34
作者
Su, Y. -C. [1 ]
Wu, M. -T. [2 ]
Huang, C. -J. [3 ]
Hou, M. -F. [4 ]
Yang, S. -F. [1 ]
Chai, C. -Y. [1 ,5 ]
机构
[1] Kaohsiung Med Univ, Chung Ho Mem Hosp, Dept Pathol, Kaohsiung 807, Taiwan
[2] Kaohsiung Med Univ, Grad Inst Occupat Safety & Hlth, Kaohsiung 807, Taiwan
[3] Kaohsiung Med Univ, Chung Ho Mem Hosp, Dept Radiat Oncol, Kaohsiung 807, Taiwan
[4] Kaohsiung Med Univ, Chung Ho Mem Hosp, Dept Surg, Kaohsiung 807, Taiwan
[5] Kaohsiung Med Univ, Coll Med, Dept Pathol, Kaohsiung 807, Taiwan
关键词
CXCR4; breast cancer; sentinel lymph node;
D O I
10.1016/j.breast.2005.08.034
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Recent studies have discovered that CXCR4 is associated with tumor metastasis. It is worth understanding the association between CXCR4 expression and axillary lymph node involvement in early breast cancer. Eighty-five patients with early breast cancers were divided into three groups based on their axillary lymph node status. CXCR4 expression was assessed by immunohistochemistry in all cases and its correlation with axillary lymph node involvement was evaluated. There was a significant difference in nuclear CXCR4 expression among these three groups and high nuclear expression of CXCR4 was associated with cases with no lymph node involvement. However, high cytoplasmic expression of CXCR4 was associated with patients who developed high-level axillary lymph node involvement. In conclusion, the different staining locations of CXCR4 have varying biological significance for the metastatic potential of axillary lymph nodes. In particular, it provided information that high cytoplasmic expression of CXCR4 was related to axillary internodal metastasis, and adjuvant radio-chemotherapy was suggested. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:533 / 539
页数:7
相关论文
共 19 条
[1]  
Almofti A, 2004, INT J ONCOL, V25, P65
[2]   A possible role for CXCR4 and its ligand, the CXC chemokine stromal cell-derived factor-1, in the development of bone marrow metastases in neuroblastoma [J].
Geminder, H ;
Sagi-Assif, O ;
Goldberg, L ;
Meshel, T ;
Rechavi, G ;
Witz, IP ;
Ben-Baruch, A .
JOURNAL OF IMMUNOLOGY, 2001, 167 (08) :4747-4757
[3]   Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients [J].
Gipponi, M ;
Bassetti, C ;
Canavese, G ;
Catturich, A ;
Di Somma, C ;
Vecchio, C ;
Nicolò, G ;
Schenone, F ;
Tomei, D ;
Cafiero, F .
JOURNAL OF SURGICAL ONCOLOGY, 2004, 85 (03) :102-111
[4]  
Grube Baiba J, 2004, Adv Surg, V38, P121
[5]   The value of sentinel lymph node biopsy in elderly breast cancer patients [J].
Hieken, TJ ;
Nettnin, S ;
Velasco, JM .
AMERICAN JOURNAL OF SURGERY, 2004, 188 (04) :440-442
[6]   CXC chemokine receptor 4 expression and function in human anaplastic thyroid cancer cells [J].
Hwang, JH ;
Hwang, JH ;
Chung, HK ;
Kim, DW ;
Hwang, ES ;
Suh, JM ;
Kim, H ;
You, KH ;
Kwon, OY ;
Ro, HK ;
Jo, DY ;
Shong, M .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (01) :408-416
[7]   Expression pattern of CXC chemokine receptor-4 is correlated with lymph node metastasis in human invasive ductal carcinoma [J].
Kato, M ;
Kitayama, J ;
Kazama, S ;
Nagawa, H .
BREAST CANCER RESEARCH, 2003, 5 (05) :R144-R150
[8]  
Koshiba T, 2000, CLIN CANCER RES, V6, P3530
[9]   Interaction of ligand-receptor system between stromal-cell-derived factor-1 and CXC chemokine receptor 4 in human prostate cancer: a possible predictor of metastasis [J].
Mochizuki, H ;
Matsubara, A ;
Teishima, J ;
Mutaguchi, K ;
Yasumoto, H ;
Dahiya, R ;
Usui, T ;
Kamiya, K .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 320 (03) :656-663
[10]   Involvement of chemokine receptors in breast cancer metastasis [J].
Müller, A ;
Homey, B ;
Soto, H ;
Ge, NF ;
Catron, D ;
Buchanan, ME ;
McClanahan, T ;
Murphy, E ;
Yuan, W ;
Wagner, SN ;
Barrera, JL ;
Mohar, A ;
Verástegui, E ;
Zlotnik, A .
NATURE, 2001, 410 (6824) :50-56